New Haven, Connecticut, December 19, 2023 – Stradefy Biosciences, a New Haven-based drug discovery and development company based on Yale University research, today announced the appointment of Jeffrey M. Goldberg as Executive Chair, effective immediately. Mr. Goldberg is an accomplished biotech executive with over 25 years of experience leading teams from preclinical discovery through commercialization. He previously served as President and Chief Executive Officer of both Immunitas Therapeutics and Aeglea Biotherapeutics, now Spyre Therapeutics.
PRESS RELEASE
MM – Stradefy Biosciences – Goldberg ExecChair Press Release December 19 2023